Dr. Laute Margo, Nefrologie SRL
Dr. Laute Margo, Nefrologie reported total assets of 417,851 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Dec 2025).
By total assets for 2025, Dr. Laute Margo, Nefrologie ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Laute Margo, Nefrologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -55 % Total assets -22 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Laute Margo, Nefrologie's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 317,805 € | ||||
| Equity | 18,600 € | ||||
| Cash | 339,041 € | ||||
| EBITDA | 452,341 € | ||||
| Total assets | 417,851 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 23 Dec 2025
- Year ended 30 Sep 2024filed on 28 Feb 2025
- Year ended 30 Sep 2023filed on 30 Jan 2024
- Year ended 30 Sep 2022filed on 31 Mar 2023
- Year ended 30 Sep 2021filed on 06 Apr 2022
Dr. Laute Margo, Nefrologie's financial analysis
- Solvency4.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Laute Margo, Nefrologie
Dr. Laute Margo, Nefrologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0688.782.053
- VAT number
- BE0688782053
- Peppol
- Registered · 0208:0688782053 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 2018
- Registered office
- 9031 Ghent
- Latest accounts
- 2025 · filed on 23 Dec 2025
- Activity
- Medical specialists activities (NACE 86220)
Dr. Laute Margo, Nefrologie (SRL) has been based in Ghent since 2018, active in: medical specialists activities. For 2025, it reports a net profit of 317,805 € and equity of 18,600 €; its revenue is not published. Its solvency stands at 4.5%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Laute Margo, Nefrologie
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dr. Laute Margo, Nefrologie
What is the revenue of Dr. Laute Margo, Nefrologie?
Dr. Laute Margo, Nefrologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Laute Margo, Nefrologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0688782053 for Dr. Laute Margo, Nefrologie, if the company is VAT-registered. Its company number (CBE) is 0688.782.053.
Where is the registered office of Dr. Laute Margo, Nefrologie?
According to the CBE register, the registered office of Dr. Laute Margo, Nefrologie is in 9031 Ghent.
What is the equity of Dr. Laute Margo, Nefrologie?
At the close of the 2025 financial year, the equity of Dr. Laute Margo, Nefrologie amounts to 18,600 €, a solvency of 4.5% of total assets.
Who manages Dr. Laute Margo, Nefrologie?
The register lists 2 active mandates at Dr. Laute Margo, Nefrologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Laute Margo, Nefrologie within its sector?
By total assets for 2025, Dr. Laute Margo, Nefrologie ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Laute Margo, Nefrologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →